WCN26-7467 Investigation of Severe Hypophosphatemia in Recipients during the Early Postoperative Period after Living Donor Kidney Transplantation

Read full text Summarise with VIRAT
Authors: Hayaki Okamoto, Shunsuke Goto, Hidehisa Okamoto, Yoji Hyodo, Hideaki MIYAKE, Hideki Fujii
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic kidney disease–mineral and bone disorder (CKD-MBD) is a well-known complication of progressive CKD. In early CKD, phosphate excretion is maintained through reduced tubular reabsorption driven by elevated parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23). As CKD advances, this mechanism fails, leading to hyperphosphatemia. Kidney transplantation, a form of renal replacement therapy, often causes a marked drop in serum phosphate early post-transplant, sometimes resulting in transient hypophosphatemia.

Fields of Study & Subjects

Parathyroid Disorders and Treatments Renal Transplantation Outcomes and Treatments Organ Donation and Transplantation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105530–105530
Publication date
25 March 2026
Language
EN